The new corona virus SARS-CoV-2 has been raging since January 2020, spreading at an unprecedented pace, exhibiting insidious properties and puzzling experts. SCHURTER has taken this fact into account and has ramped up the production of its medical products.
Thanks to decades of expertise in manufacturing as a supplier of medical technology, SCHURTER was able to avert the lockdown of many of its production facilities. Pandemic and system-relevant plants were closed in very few countries.
SCHURTER took advantage of this situation and decided to drastically increase its capacities in favour of the production of components and input systems for medical technology.
Microchip’s MCPF1525 power module with PMBus™ delivers 25A DC-DC power, stackable up to 200A The…
New AI-powered platform – the first with full ERP integration – includes an AI agent…
The study validated the CORA system’s ability to rule out coronary artery disease with a…
Factify replaces static PDFs with authoritative, intelligent records that allow AI to take charge of…
Mesh Security, the company delivering the world’s first Cybersecurity Mesh Architecture (CSMA) platform, today announced…
New review by the investment firm examines how climate-tech investors are pivoting toward reliability, AI…
